10 pharma CEOs called on to join AIDS medicines patent pool
This article was originally published in Scrip
Board members representing NGOs and communities in low and middle income countries for UNITAID, the international drug purchasing facility, have written to 10 pharma CEOs asking them to join the voluntary AIDS medicines patent pool, which aims to produce affordable fixed-dose combination HIV therapies for developing countries. 38 civil society organisations, mostly advocating HIV issues, have also signed onto the letter, including Stop AIDS Alliance, Knowledge Ecology International and Health GAP.
You may also be interested in...
The US Food and Drug Administration recently signalled its desire to work more closely with other drug regulators in assessing the quality of pharmaceutical manufacturing facilities around the world.
It seems as if the US FDA is softening its stance on assessing the quality of pharmaceutical manufacturing facilities around the world in future, with an apparent desire to work more closely with other drug regulators. However, incorporating the regulators from countries such as India, China and Japan into a global inspectorate still looks problematical.
Large pharmaceutical companies and Médecins sans Frontières may not often see eye-to-eye over access to medicines in poor countries. But it seems as if industry and the humanitarian body, a prominent critic, do agree that competition works in improving access to vaccines, even though they don't agree about the mechanisms of price setting.